Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDIV 1

Study Type

Observational 2Interventional 1

Sponsor

Conditions

Multiple Myeloma 7Prostatic Neoplasms 3Myasthenia Gravis 3Lymphoma 3Plasmacytoma 2Paraproteinemias 2Neoplasms 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Leukemia, Plasma Cell 2Hemangioma 2Breast Neoplasms 2Anatomic Stage IV Breast Cancer AJCC v8 2Spinal Cord Compression 1Recurrence 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatitis 1Head and Neck Neoplasms 1Glioma 1Gallstones 1Esophageal Stenosis 1

Interventions

rozanolixizumab 11efgartigimod alfa 10zilucoplan 8Prednisone 8Cyclophosphamide 8ravulizumab 7Rituximab 7Pyridostigmine Bromide 7telitacicept 6fludarabine 6Tacrolimus 6Mycophenolic Acid 6eculizumab 5Immunoglobulins, Intravenous 5Hizentra 4Azathioprine 4Steroids 3HBM9161 3Data Collection 3Amifampridine 3thymoglobulin 2inebilizumab 2Thymectomy 2Prednisolone 2Methylprednisolone 2Methotrexate 2Exercise 2Diagnostic Self Evaluation 2Blood Specimen Collection 2tofacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Myasthenia Gravis × Steroids × Clear all
NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Recruiting
200 enrolled

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated
11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡